LEADER 01956nam a2200325 u 4500
001 EB000943518
003 EBX01000000000000000737108
005 00000000000000.0
007 tu|||||||||||||||||||||
008 150223 r ||| eng
100 1 |a McDonagh, Marian S. 
245 0 0 |a Drug class review on agents for overactive bladder  |h Elektronische Ressource  |b final report  |c Marian S. McDonagh ... [et al.] 
260 |a Portland, Or.  |b Oregon Health & Science University, Evidence-Based Practice Center  |c c2005, 2005 
300 |a 1 PDF file (215 p.)  |b ill 
505 0 |a Includes bibliographical references 
653 |a Drug Evaluation 
653 |a United States 
653 |a Clinical Trials as Topic 
653 |a Cholinergic Antagonists / therapeutic use 
653 |a Quality of Life 
653 |a Urinary Incontinence / drug therapy 
653 |a Muscarinic Antagonists / therapeutic use 
653 |a Urinary Bladder, Overactive / drug therapy 
710 2 |a Oregon Health & Science University  |b Evidence-based Practice Center 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
500 |a "December 2005.". - "The purpose of this report is to make available information regarding the comparative effectiveness and safety profiles of different drugs within pharmaceutical classes. Reports are not usage guidelines, nor should they be read as an endorsement of, or recommendation for, any particular drug, use or approach. Oregon Health & Science University does not recommend or endorse any guideline or recommendation developed by users of these reports." 
856 4 0 |u http://el.trc.gov.om:4000/htmlroot/MEDICAL/tcolon/pharmacology/Drug%20Effectiveness/E-Books/Drug%20Class%20Review%20on%20Agents%20for%20Overactive%20Bladder.pdf  |3 Volltext  |n Free Electronic Resource  |3 Volltext 
856 4 0 |u https://www.ncbi.nlm.nih.gov/books/NBK10412  |3 Volltext  |n NLM Bookshelf Books  |3 Volltext 
082 0 |a 610